{ "nodes": [ { "id": 1, "label": "Query__CQURYPUSER", "query": "How would patients react if their doctors started prescribing nature walks instead of pharmaceuticals for mild depression treatment?" }, { "id": 2, "label": "What-If Scenario__CQURYFHYSC" }, { "id": 5, "label": "Key Assumptions__CQURYFHYSS" }, { "id": 7, "label": "Logical Outcomes__CQURYFHYCN" }, { "id": 9, "label": "Branching Possibilities__CQURYFHYLT" }, { "id": 11, "label": "Real-World Takeaway__CQURYFHYMP" }, { "id": 13, "label": "Regime Transition__CQURYFHYMPDTMPR" }, { "id": 14, "label": "Nature Prescriptions__CJ43XPQURY", "query": "What would happen to the prescription of nature walks if doctors were financially rewarded for patient outcomes rather than for services delivered?" }, { "id": 15, "label": "Baseline Readout__CQURYFHYSCDMMRY" }, { "id": 16, "label": "Nature Walk Prescriptions__CZXSCPQURY", "query": "Would patients adhere more to nature walk prescriptions if they were reimbursed at the same rate as psychotherapy sessions?" }, { "id": 17, "label": "Clashing Views__CQURYFHYLTDCNTR" }, { "id": 18, "label": "Nature Prescriptions Fail__C7NY3PQURY", "query": "Would patients in higher-income brackets also show low adherence to nature walk prescriptions if their access to green space were equally constrained?" }, { "id": 19, "label": "Overlooked Angles__CQURYFHYSCDBLND" }, { "id": 20, "label": "Nature Walks In Healthcare__C7I1JPQURY", "query": "What would happen to the adoption of nature-based mental health treatments if insurance reimbursement policies were suddenly decoupled from the requirement for standardized, billable service units?" }, { "id": 21, "label": "Clashing Views__CQURYFHYMPDCNTR" }, { "id": 22, "label": "Nature Walk Prescriptions__CRHMFPQURY", "query": "What happens to patient adherence when nature walks are prescribed outside any recognized therapeutic protocol but are still recommended by trusted physicians?" }, { "id": 23, "label": "What-If Scenario__CRHMFFHYSC" }, { "id": 25, "label": "Key Assumptions__CRHMFFHYSS" }, { "id": 27, "label": "Logical Outcomes__CRHMFFHYCN" }, { "id": 29, "label": "Branching Possibilities__CRHMFFHYLT" }, { "id": 31, "label": "Real-World Takeaway__CRHMFFHYMP" }, { "id": 33, "label": "Regime Transition__CRHMFFHYSCDTMPR" }, { "id": 34, "label": "Nature Walk Prescriptions__CJ9JYPRHMF", "query": "Would patients still follow nature walk prescriptions if they were included in official treatment protocols but their doctors objected to their clinical value?" }, { "id": 35, "label": "Baseline Readout__CRHMFFHYMPDMMRY" }, { "id": 36, "label": "Nature Walk Prescriptions__CNNBUPRHMF" }, { "id": 37, "label": "What-If Scenario__C7NY3FHYSC" }, { "id": 39, "label": "Key Assumptions__C7NY3FHYSS" }, { "id": 41, "label": "Logical Outcomes__C7NY3FHYCN" }, { "id": 43, "label": "Branching Possibilities__C7NY3FHYLT" }, { "id": 45, "label": "Real-World Takeaway__C7NY3FHYMP" }, { "id": 47, "label": "Concrete Instances__C7NY3FHYMPDXMPL" }, { "id": 48, "label": "Park Access Gap__CFS0CP7NY3", "query": "If access to green space is the critical factor shaping adherence to nature walk prescriptions, why do some cities with comparable levels of green infrastructure still show significant differences in patient engagement with non-pharmaceutical interventions?" }, { "id": 49, "label": "Baseline Readout__C7NY3FHYSSDMMRY" }, { "id": 50, "label": "Nature Prescription Gap__C2U2KP7NY3" }, { "id": 51, "label": "The Operative Context__CRHMFFHYCNDCNTX" }, { "id": 52, "label": "Nature Walk Prescriptions__C0P04PRHMF" }, { "id": 53, "label": "What-If Scenario__CZXSCFHYSC" }, { "id": 55, "label": "Key Assumptions__CZXSCFHYSS" }, { "id": 57, "label": "Logical Outcomes__CZXSCFHYCN" }, { "id": 59, "label": "Branching Possibilities__CZXSCFHYLT" }, { "id": 61, "label": "Real-World Takeaway__CZXSCFHYMP" }, { "id": 63, "label": "The Operative Context__CZXSCFHYMPDCNTX" }, { "id": 64, "label": "Nature Walk Prescriptions__CBSCIPZXSC", "query": "Would patients still view nature walks as equally legitimate if insurance coverage was removed but doctors continued to recommend them?" }, { "id": 65, "label": "What-If Scenario__C7I1JFHYSC" }, { "id": 67, "label": "Key Assumptions__C7I1JFHYSS" }, { "id": 69, "label": "Logical Outcomes__C7I1JFHYCN" }, { "id": 71, "label": "Branching Possibilities__C7I1JFHYLT" }, { "id": 73, "label": "Real-World Takeaway__C7I1JFHYMP" }, { "id": 75, "label": "Overlooked Angles__C7I1JFHYLTDBLND" }, { "id": 76, "label": "Nature Prescription Problem__CIN1DP7I1J" }, { "id": 77, "label": "What-If Scenario__CJ43XFHYSC" }, { "id": 79, "label": "Key Assumptions__CJ43XFHYSS" }, { "id": 81, "label": "Logical Outcomes__CJ43XFHYCN" }, { "id": 83, "label": "Branching Possibilities__CJ43XFHYLT" }, { "id": 85, "label": "Real-World Takeaway__CJ43XFHYMP" }, { "id": 87, "label": "Overlooked Angles__CJ43XFHYSCDBLND" }, { "id": 88, "label": "Nature Walks As Therapy__C39PRPJ43X", "query": "Could patients begin to view nature walks as legitimate treatment if primary care providers were required to document and verify participation in a way that mirrors clinical encounters, even without financial reimbursement?" }, { "id": 89, "label": "Clashing Views__C7I1JFHYSSDCNTR" }, { "id": 90, "label": "Tracking Shapes Treatment__CAQGRP7I1J" }, { "id": 91, "label": "Overlooked Angles__C7I1JFHYSCDBLND" }, { "id": 92, "label": "Nature Walks In Healthcare__CEU3TP7I1J" }, { "id": 93, "label": "Overlooked Angles__CZXSCFHYLTDBLND" }, { "id": 94, "label": "Nature Walk Prescriptions__CUCS2PZXSC", "query": "Would patients adhere to nature walk prescriptions if they were reimbursed but delivered by non-clinical staff, bypassing licensed practitioners?" }, { "id": 95, "label": "The Problem__CFS0CFPRPB" }, { "id": 97, "label": "Contributing Factors__CFS0CFPRPC" }, { "id": 99, "label": "Diagnostic Tests__CFS0CFPRDG" }, { "id": 101, "label": "Root-Cause Fixes__CFS0CFPRSL" }, { "id": 103, "label": "Feasibility Limits__CFS0CFPRRA" }, { "id": 105, "label": "Concrete Instances__CFS0CFPRRADXMPL" }, { "id": 106, "label": "Park Access Gap__CO8Y6PFS0C" }, { "id": 107, "label": "What-If Scenario__CBSCIFHYSC" }, { "id": 109, "label": "Key Assumptions__CBSCIFHYSS" }, { "id": 111, "label": "Logical Outcomes__CBSCIFHYCN" }, { "id": 113, "label": "Branching Possibilities__CBSCIFHYLT" }, { "id": 115, "label": "Real-World Takeaway__CBSCIFHYMP" }, { "id": 117, "label": "Concrete Instances__CBSCIFHYCNDXMPL" }, { "id": 118, "label": "Insurance Coverage Effect__CDKX4PBSCI" }, { "id": 119, "label": "Origins and Triggers__CUCS2FCSRT" }, { "id": 121, "label": "Causal Mechanisms__CUCS2FCSMC" }, { "id": 123, "label": "Effects and Outcomes__CUCS2FCSFF" }, { "id": 125, "label": "Moderating Factors__CUCS2FCSMD" }, { "id": 127, "label": "Early Signals__CUCS2FCSCR" }, { "id": 129, "label": "Causal Constraints__CUCS2FCSCS" }, { "id": 131, "label": "Regime Transition__CUCS2FCSFFDTMPR" }, { "id": 132, "label": "Nature Walk Prescriptions__CIXITPUCS2" }, { "id": 133, "label": "Origins and Triggers__CJ9JYFCSRT" }, { "id": 135, "label": "Causal Mechanisms__CJ9JYFCSMC" }, { "id": 137, "label": "Effects and Outcomes__CJ9JYFCSFF" }, { "id": 139, "label": "Moderating Factors__CJ9JYFCSMD" }, { "id": 141, "label": "Early Signals__CJ9JYFCSCR" }, { "id": 143, "label": "Causal Constraints__CJ9JYFCSCS" }, { "id": 145, "label": "The Operative Context__CJ9JYFCSRTDCNTX" }, { "id": 146, "label": "Nature Walk Prescriptions__CGLKKPJ9JY" }, { "id": 147, "label": "What-If Scenario__C39PRFHYSC" }, { "id": 149, "label": "Key Assumptions__C39PRFHYSS" }, { "id": 151, "label": "Logical Outcomes__C39PRFHYCN" }, { "id": 153, "label": "Branching Possibilities__C39PRFHYLT" }, { "id": 155, "label": "Real-World Takeaway__C39PRFHYMP" }, { "id": 157, "label": "Baseline Readout__C39PRFHYCNDMMRY" }, { "id": 158, "label": "Nature Walk Treatment__C84B4P39PR" }, { "id": 159, "label": "The Operative Context__CUCS2FCSMCDCNTX" }, { "id": 160, "label": "Nature Walk Prescriptions__CBWC8PUCS2" }, { "id": 161, "label": "Overlooked Angles__CFS0CFPRDGDBLND" }, { "id": 162, "label": "Park Prescriptions__CDO0TPFS0C" } ], "edges": [ { "source": 1, "target": 2, "relationship": "__anchor__" }, { "source": 1, "target": 5, "relationship": "__anchor__" }, { "source": 1, "target": 7, "relationship": "__anchor__" }, { "source": 1, "target": 9, "relationship": "__anchor__" }, { "source": 1, "target": 11, "relationship": "__anchor__" }, { "source": 11, "target": 13, "relationship": "__anchor__" }, { "source": 13, "target": 14, "relationship": "**Nature prescriptions remain uncommon because healthcare payment systems favor billable, clinic-based treatments over preventive, non-clinical activities.**\n\nDoctors rarely recommend nature walks for mild depression, even though research supports their benefits. This is because healthcare systems in wealthy countries pay mainly for treatments given in medical offices. These systems reward services that can be easily measured and billed. Nature walks happen outside clinics and are hard to bill for. As a result, doctors have little financial reason to suggest them. Even guidelines that support nature-based therapy cannot change practice if payment rules do not. So, decisions about treatment depend more on how care is paid for than on what works best. Without changes in how providers get paid, nature prescriptions will stay rare." }, { "source": 2, "target": 15, "relationship": "__anchor__" }, { "source": 15, "target": 16, "relationship": "**Nature walk prescriptions fail to gain lasting use because the medical system gives drugs more legitimacy and support.**\n\nMajor health systems in the United States favor drug treatments for mental health. This preference is built into how care is regulated and paid for. Agencies like the American Psychiatric Association and the National Institute of Mental Health mainly endorse medication-based treatments. Non-drug options, such as nature walks, are treated as less important. Even when these alternatives help with mild depression, they get little support. Insurance systems reimburse drugs easily but not nature walks. Medical training focuses on pharmaceuticals, not other therapies. Doctors are used to prescribing pills, not outdoor activities. Changing this habit means changing the whole system. The infrastructure around medicine rewards drugs. For nature walks to be taken seriously, they need the same level of institutional backing. Without it, patients may accept the idea at first but will not stick with it. Most people expect proven, familiar treatments. They follow prescriptions more when they see them as legitimate. Nature walks lack that trust. As a result, few patients keep up with them. The system must change for this to work." }, { "source": 9, "target": 17, "relationship": "__anchor__" }, { "source": 17, "target": 18, "relationship": "**Nature walk prescriptions fail for low-income patients because unsafe neighborhoods and lack of green space make access physically impossible, not due to medical or financial barriers.**\n\nIn high-income countries, people with lower incomes face higher rates of mild depression. Doctors may prescribe nature walks to help. But many cannot follow this advice. Poor neighborhoods often lack safe parks or green spaces. Many also work long hours or multiple jobs. These conditions make it hard to find time or safe places for walks. Health advice does not help if people cannot reach nature safely. Even if insurance covers the cost, access remains limited. The main barrier is not medical bias or funding rules. It is the material conditions of people's lives. Lower-income patients often live in places without nearby green space. They face real-world barriers to following nature prescriptions. This makes the treatment impossible for many. So, most will not start or keep up with the walks. The problem is not the idea but where people live and work. Socioeconomic conditions block the path to better mental health." }, { "source": 2, "target": 19, "relationship": "__anchor__" }, { "source": 19, "target": 20, "relationship": "**Nature-based mental health treatments can be adopted in healthcare systems when community support programs exist, because these programs allow access without relying on billing through clinical services.**\n\nClinical guidelines and insurance policies in wealthy countries often support treatments that are easy to measure and bill. This focus shapes how doctors choose treatments. It favors services that happen in clinics and can be counted. As a result, non-clinical options like nature walks get left out. These walks are not paid for directly and do not happen in medical settings. Yet studies show they can help mental health. Even so, some health systems have found ways to include them. In the UK, social prescribing lets doctors refer patients to nature activities. These programs are part of primary care and get local funding. When such support exists, access to nature-based treatment improves. This shows that the main barrier is not cost alone. The real issue is the lack of organized systems to support these activities outside clinics." }, { "source": 11, "target": 21, "relationship": "__anchor__" }, { "source": 21, "target": 22, "relationship": "**Nature walks become effective treatments for mild depression only when they are part of a formally approved therapy protocol, because clinical legitimacy determines patient adherence and doctor compliance.**\n\nPrimary care often treats mild depression with short courses of cognitive behavioral therapy. This approach is used in the UK and copied in other countries. It relies on government-backed standards for non-drug treatments. These standards make therapies reimbursable and scalable. They also give treatments clinical credibility. Without this recognition, even sensible ideas like nature walks struggle to be taken seriously. Doctors are unlikely to prescribe them. Patients are unlikely to follow through. For nature walks to work as treatment, they must first be part of an approved therapy plan. Only when health systems recognize them as legitimate will patients and doctors take them seriously. Clinical approval shapes funding and patient behavior, not the other way around. The key is formal recognition by medical authorities. That determines what treatments get used." }, { "source": 22, "target": 23, "relationship": "__anchor__" }, { "source": 22, "target": 25, "relationship": "__anchor__" }, { "source": 22, "target": 27, "relationship": "__anchor__" }, { "source": 22, "target": 29, "relationship": "__anchor__" }, { "source": 22, "target": 31, "relationship": "__anchor__" }, { "source": 23, "target": 33, "relationship": "__anchor__" }, { "source": 33, "target": 34, "relationship": "**Patient adherence to non-drug treatments like nature walks increases only when they are formally integrated into state-backed care systems, because systemic validation signals legitimacy and triggers accountability.**\n\nIn national health systems, psychological treatments must be officially accredited to receive funding and clinical support. Without formal recognition, even trusted doctor advice often fails to change patient behavior. For example, telling patients to take nature walks usually does not work if it is not part of an approved care plan. The UK's IAPT program shows how formal backing increases patient follow-through. It set clear standards, training, and tracking for cognitive behavioral therapy. This made the treatment seem trustworthy and actionable. Patients are more likely to comply when a treatment is part of an official system. They see it as legitimate because it is monitored and reimbursed. Doctors also take it more seriously because it is part of their professional duties. When nature walks are included in these official frameworks, patients follow them more consistently. It is not the doctor's advice alone that matters. It is the system's stamp of approval that makes the difference. Formal integration signals validity and accountability. That shift in perception drives real behavioral change." }, { "source": 31, "target": 35, "relationship": "__anchor__" }, { "source": 35, "target": 36, "relationship": "**Nature walk prescriptions work when they are part of an official plan because patients and doctors trust system-backed guidelines more than informal advice.**\n\nWhen doctors recommend nature walks for depression, patients follow through only if the advice is part of an official treatment plan. Primary care systems rely on standardized guidelines to approve treatments. Without formal backing, even sensible advice is treated as optional. Doctors depend on trusted bodies like NICE to justify non-drug treatments. Patients see value in activities only when they are prescribed within recognized programs. Treatments gain legitimacy through system approval, not just medical endorsement. Nature walks are no different. They become effective only when embedded in structured care pathways. Patient adherence improves because the system’s authority makes the recommendation feel necessary. This pattern repeats across health systems. Institutional recognition decides which non-drug therapies succeed in practice." }, { "source": 18, "target": 37, "relationship": "__anchor__" }, { "source": 18, "target": 39, "relationship": "__anchor__" }, { "source": 18, "target": 41, "relationship": "__anchor__" }, { "source": 18, "target": 43, "relationship": "__anchor__" }, { "source": 18, "target": 45, "relationship": "__anchor__" }, { "source": 45, "target": 47, "relationship": "__anchor__" }, { "source": 47, "target": 48, "relationship": "**Unequal park access reduces adherence to nature-based health advice because proximity and safety determine whether people can follow prescriptions, regardless of income.**\n\nIn wealthy countries, zoning rules favor housing and businesses over parks and green spaces. This reduces access to safe natural areas in poorer neighborhoods. Long-term studies show people moved to such areas still suffer more depression. This happens not because they doubt the value of nature, but because parks are too far or unsafe to reach. Even wealthier people exercise less outdoors when green spaces are not within a 15-minute walk. Data from national surveys confirm activity drops across income levels when access is poor. The same structural barrier affects everyone when green space is distant. Therefore, if everyone faced the same lack of nearby nature, even high-income individuals would fail to follow nature-based health advice. This is not due to cost or disbelief. It happens because walking prescriptions only work where nature is close and safe to reach." }, { "source": 39, "target": 49, "relationship": "__anchor__" }, { "source": 49, "target": 50, "relationship": "**Nature prescriptions fail in low-income areas because the built environment restricts access to green space, making adherence impossible regardless of motivation.**\n\nIn wealthy countries, city planning often favors homes and businesses over parks and green spaces. This means access to nature depends on property prices and neighborhood design. Health programs that prescribe time in nature work better in rich areas. These areas already have more parks and protected spaces. Poorer areas, often segregated by race, lack safe and easy access to green spaces. Even with medical advice, people in these areas cannot follow nature walk prescriptions. The problem is not motivation or culture. The built environment limits routine physical activity. Green space access is a prerequisite for compliance. When this access is missing, adherence drops sharply. In rich neighborhoods, adherence would also fall if green space were limited. The physical layout of a city shapes behavior more than income or education." }, { "source": 27, "target": 51, "relationship": "__anchor__" }, { "source": 51, "target": 52, "relationship": "**Nature walk prescriptions become effective only when integrated into formal clinical pathways because systematic recognition and follow-up drive patient adherence.**\n\nDoctors may recommend nature walks to patients. Yet these recommendations often fail to take hold. This happens even when clinicians support them. The reason is that such advice does not fit into standard medical workflows. Clinical care in the U.S. Veterans Health Administration follows set procedures. These procedures rely on coded, billable services. Nature walks are not coded in medical records. They do not appear in performance reviews. Without such recognition, they remain informal suggestions. They are not treated as real treatment. Chronic disease care works best when patients expect follow-up. Accountability and structured planning increase adherence. Nature walks only gain traction when they are part of official care plans. They must be recorded in electronic systems. They need to be tracked like other treatments. Only then do patients follow through. Structural integration makes them visible. It signals that the treatment matters. Trust in a doctor is not enough on its own. The system must recognize the activity as medicine. Then it becomes real care." }, { "source": 16, "target": 53, "relationship": "__anchor__" }, { "source": 16, "target": 55, "relationship": "__anchor__" }, { "source": 16, "target": 57, "relationship": "__anchor__" }, { "source": 16, "target": 59, "relationship": "__anchor__" }, { "source": 16, "target": 61, "relationship": "__anchor__" }, { "source": 61, "target": 63, "relationship": "__anchor__" }, { "source": 63, "target": 64, "relationship": "**Patients would follow nature walk prescriptions as closely as psychotherapy if they were reimbursed at the same rate, because insurance coverage signals medical legitimacy and drives adherence.**\n\nIn the U.S., medical treatments gain patient adherence not because they are proven effective but because they are officially recognized and covered by insurance. Antidepressant drugs are quickly adopted because they are approved by the FDA and included in billing codes covered by Medicare. In contrast, nature walks are rarely covered, even though studies show they reduce depression symptoms. Patients see insurance coverage as a sign that a treatment is necessary and legitimate. When nature walks are reimbursed at the same rate as therapy, patients treat them with the same seriousness. This financial parity places nature walks on equal footing with clinical treatments. As a result, patients follow through with them just as consistently. Reimbursement shapes patient behavior by signaling legitimacy." }, { "source": 20, "target": 65, "relationship": "__anchor__" }, { "source": 20, "target": 67, "relationship": "__anchor__" }, { "source": 20, "target": 69, "relationship": "__anchor__" }, { "source": 20, "target": 71, "relationship": "__anchor__" }, { "source": 20, "target": 73, "relationship": "__anchor__" }, { "source": 71, "target": 75, "relationship": "__anchor__" }, { "source": 75, "target": 76, "relationship": "**Nature-based health recommendations only improve adherence when paired with a billing system because providers cannot routinely track or support what insurers do not pay to monitor.**\n\nIn national health systems, treatments without pills often struggle to take hold. This is not just because they lack official approval. The real issue lies in how care is paid for. Most insurance systems reimburse only services that can be billed by the minute. These are usually face-to-face meetings between provider and patient. Non-drug treatments, like spending time in nature, often fall outside this model. They are not supervised and cannot be easily billed. As a result, even if such treatments are endorsed by health authorities, they do not become routine. For example, approved therapy programs fail to spread beyond specialized centers. Simply putting nature-based treatments into official guidelines does not make patients follow them. The key missing piece is a way to pay for follow-up visits. Without a billing code, providers cannot schedule check-ins. This makes the treatment easy to ignore in daily care plans. When billing codes exist alongside guidelines, adherence improves. The ability to track and bill for support turns recommendations into action. Therefore, formal approval alone changes little. Only when codification comes with a payment mechanism does patient adherence rise." }, { "source": 14, "target": 77, "relationship": "__anchor__" }, { "source": 14, "target": 79, "relationship": "__anchor__" }, { "source": 14, "target": 81, "relationship": "__anchor__" }, { "source": 14, "target": 83, "relationship": "__anchor__" }, { "source": 14, "target": 85, "relationship": "__anchor__" }, { "source": 77, "target": 87, "relationship": "__anchor__" }, { "source": 87, "target": 88, "relationship": "**Nature walks are not seen as equivalent to therapy because the billing system does not support tracking or verifying them as formal treatments.**\n\nThe way health care billing works favors treatments that can be clearly documented and charged for. This system prefers standard clinical visits over activities like nature walks. Nature walks are not easily recorded using current medical billing codes. Even if research shows health benefits, they lack formal treatment protocols. Other non-drug therapies, like lifestyle counseling, are also underused. These services are covered but still require verification and monitoring systems. Patients and providers treat billed services as more legitimate. Without a clear way to track and verify participation, people don't see nature walks as real treatment. Reimbursement alone does not make patients follow through. The structure of billing and tracking shapes what counts as real care. True equivalence requires more than just payment parity. It needs formal recognition and a way to monitor treatment." }, { "source": 67, "target": 89, "relationship": "__anchor__" }, { "source": 89, "target": 90, "relationship": "**Patient adherence to non-drug mental health treatments rises when routine measurement creates an ongoing clinical process that keeps people engaged.**\n\nNational health systems often favor drug treatments because they are easier to measure and track. This preference is clear in guidelines from groups like NICE and the WHO. These systems rely on standard ways to monitor results, such as the UK's Quality and Outcomes Framework or the U.S. HEDIS metrics. Such systems value hard numbers over patient well-being reports. As a result, non-drug treatments struggle to take hold, even when recommended. For example, psychosocial referrals in the UK's IAPT program are underused. This happens not because they lack approval, but because they lack follow-up tracking. Patients stick with nature-based treatments much more when their progress is tracked regularly. Regular check-ins using tools like Patient Health Questionnaires make a clear clinical path. This ongoing attention keeps patients involved. Even low-intensity care works better when it includes structured follow-up. What drives patient adherence is not just official endorsement. It is the routine measurement and review that maintain engagement over time." }, { "source": 65, "target": 91, "relationship": "__anchor__" }, { "source": 91, "target": 92, "relationship": "**Nature walks remain unused in routine care because without official procedural codes, they cannot be tracked or reinforced by health systems.**\n\nHealth systems in rich countries use standard codes to track medical services. These codes decide which treatments go into patient records. They also determine what counts in quality reviews and performance measures. Only services with codes become routine care. Without a code, a treatment is not tracked. This is true even if doctors recommend it. For example, self-care activities often lack codes. They are left out of digital health systems. The same problem affects nature-based treatments. In primary care, many patients are told to take nature walks. But these are not coded in major health systems. So they do not appear in official records. This makes them invisible in care follow-up. It also reduces their standing as real medical advice. A clear result follows. If nature walks have no official code, they will not become standard. This will be true even if patients want them and insurance pays. Lack of coding means no tracking. No feedback. No support from the health system." }, { "source": 59, "target": 93, "relationship": "__anchor__" }, { "source": 93, "target": 94, "relationship": "**Nature walk prescriptions see low adherence because without equal payment, they lack legitimacy and priority in clinical practice.**\n\nHealth systems in wealthy countries pay for medical services based on fixed time units with licensed providers. This creates a strong link between what gets paid for and what gets done. When treatments are tied to billing codes, both patients and doctors see them as more legitimate. Even if nature walks were added to treatment plans with proper records and follow-up, few patients would stick to them. Without payment, doctors treat these activities as less important. This is why preventive care without reimbursement sees little use, even when experts recommend it. Payment signals value in the system, whether or not a treatment has real health benefits. So adherence stays low when nature-based therapy lacks financial support. The system treats it as secondary. What gets paid gets prioritized. That is how reimbursement drives medical behavior." }, { "source": 48, "target": 95, "relationship": "__anchor__" }, { "source": 48, "target": 97, "relationship": "__anchor__" }, { "source": 48, "target": 99, "relationship": "__anchor__" }, { "source": 48, "target": 101, "relationship": "__anchor__" }, { "source": 48, "target": 103, "relationship": "__anchor__" }, { "source": 103, "target": 105, "relationship": "__anchor__" }, { "source": 105, "target": 106, "relationship": "**Park use varies between cities with similar total green space because zoning decisions break pedestrian access, making parks unreachable by foot even when they exist.**\n\nCities often plan green spaces using strict zoning rules. These rules decide where parks go and how they connect to homes. Access to nature does not depend on how much parkland there is. It depends on how close parks are to homes and whether people can walk to them. Even cities with the same total park area show big differences in park use. This happens because zoning can place parks far from homes. Often, parks sit beyond busy roads, rail lines, or zones that block walking routes. Data from national health surveys show people move less outdoors when forced to cross these barriers. This drop in activity occurs across income levels. It is not due to personal choice or fear of crime. It is due to broken walking paths caused by zoning. When zoning severs pedestrian links, walking to parks becomes impossible. The result is that park prescriptions fail. This occurs even if parks exist on maps. Zoning rules make them unreachable. The physical layout blocks access. Therefore, zoning patterns explain why park use varies so much between cities." }, { "source": 64, "target": 107, "relationship": "__anchor__" }, { "source": 64, "target": 109, "relationship": "__anchor__" }, { "source": 64, "target": 111, "relationship": "__anchor__" }, { "source": 64, "target": 113, "relationship": "__anchor__" }, { "source": 64, "target": 115, "relationship": "__anchor__" }, { "source": 111, "target": 117, "relationship": "__anchor__" }, { "source": 117, "target": 118, "relationship": "**Patients view treatments as more legitimate when insurance covers them, because coverage signals medical value, so removing coverage would reduce adherence even if doctors still recommend the treatment.**\n\nMedicare's decision to cover a treatment influences how seriously patients take it. This is true even when doctors recommend the treatment. When Medicare began paying for cardiac rehab, more patients joined. Enrollment rose over 40 percent. Doctors had recommended it all along. The change was coverage, not advice. Patients see insurance coverage as a sign of medical value. Treatments without coverage seem less important. This happens even if they are as effective as covered ones. Non-drug treatments often lack this support. Walks in nature may be helpful. But they are not covered like drugs or procedures. Patients see this difference. They treat covered services as more legitimate. Removing coverage sends a message. It tells patients the treatment is not essential. This weakens adherence. Even with a doctor's advice, patients follow the coverage rule." }, { "source": 94, "target": 119, "relationship": "__anchor__" }, { "source": 94, "target": 121, "relationship": "__anchor__" }, { "source": 94, "target": 123, "relationship": "__anchor__" }, { "source": 94, "target": 125, "relationship": "__anchor__" }, { "source": 94, "target": 127, "relationship": "__anchor__" }, { "source": 94, "target": 129, "relationship": "__anchor__" }, { "source": 123, "target": 131, "relationship": "__anchor__" }, { "source": 131, "target": 132, "relationship": "**Patients do not adhere to nature walk prescriptions led by non-clinical staff because the healthcare system only recognizes treatments tied to billable codes and licensed providers.**\n\nIn wealthy health systems, payment rules favor treatments given by licensed clinicians in set time slots. This means non-clinical staff cannot easily offer therapeutic services, even if they work. Nature-based activities led by non-clinicians are not treated as real medical care because they lack billing codes. Medicare and Medicaid rules reinforce this by only paying for services tied to licensed providers. Even when partial payment exists, patients and doctors take treatments more seriously when money is involved. Without equal payment and provider status, nature walks are seen as extra, not essential. Patients are unlikely to follow nature walk plans led by non-clinical staff because the system does not recognize these activities as real medical treatment." }, { "source": 34, "target": 133, "relationship": "__anchor__" }, { "source": 34, "target": 135, "relationship": "__anchor__" }, { "source": 34, "target": 137, "relationship": "__anchor__" }, { "source": 34, "target": 139, "relationship": "__anchor__" }, { "source": 34, "target": 141, "relationship": "__anchor__" }, { "source": 34, "target": 143, "relationship": "__anchor__" }, { "source": 133, "target": 145, "relationship": "__anchor__" }, { "source": 145, "target": 146, "relationship": "**Nature walk prescriptions only lead to patient adherence when they are part of a formal, state-supported system that ensures monitoring, reimbursement, and doctor endorsement.**\n\nIn countries with centralized health systems, treatments must follow official standards to qualify for public funding. Patients are more likely to follow non-drug treatments when these are part of national care programs. The UK showed this with its therapy program, where psychological treatment became routine and trackable. When treatments are included in such systems, they gain weight because doctors follow state-approved rules. These rules affect insurance, monitoring, and professional duties. This makes patients trust the treatment more. But nature-based treatments like nature walks often lack this support. Even if listed in guidelines, they are not taken seriously if doctors doubt their value. Patients usually do not follow them if their doctor does not endorse them. Without being part of a formal, monitored system, such treatments have little effect. Only when nature walks are built into a structured, funded, and supervised system do patients tend to stick with them. Systemic backing and doctor approval must both exist for patients to comply." }, { "source": 88, "target": 147, "relationship": "__anchor__" }, { "source": 88, "target": 149, "relationship": "__anchor__" }, { "source": 88, "target": 151, "relationship": "__anchor__" }, { "source": 88, "target": 153, "relationship": "__anchor__" }, { "source": 88, "target": 155, "relationship": "__anchor__" }, { "source": 151, "target": 157, "relationship": "__anchor__" }, { "source": 157, "target": 158, "relationship": "**Patients do not see nature walks as legitimate treatment because they lack integration into medical records and diagnostic coding systems, which serve as key markers of legitimacy.**\n\nFederal healthcare rules require treatments to be documented with service logs, time stamps, and procedure codes. These rules come from Medicare and are copied by private insurers. Without this documentation, treatments are not seen as evidence-based, no matter how effective they might be. Patients rely on official records to judge if a treatment is real or not. They look for signed care plans and progress notes tied to diagnoses. These records act as proof of legitimacy. For example, telehealth was not trusted at first, even though studies showed it worked. That delay happened because it lacked formal documentation. Even if doctors certified that a patient took a nature walk, it would not be seen as real treatment. The reason is simple. Nature walks do not get recorded in medical records or linked to diagnosis codes. They are not part of standard medical workflows. This gap stops patients from thinking of nature walks as real medical care. The same problem has been seen with diet and sleep advice under health reform laws. Without a way to track them in medical records, patients do not accept them." }, { "source": 121, "target": 159, "relationship": "__anchor__" }, { "source": 159, "target": 160, "relationship": "**Patients follow nature walk prescriptions less than standard treatments when non-clinical staff deliver them because the absence of a licensed provider reduces perceived medical authority and trust.**\n\nIn wealthy countries, health systems pay doctors for services based on timed visits. These systems give doctors control over treatment plans. Patients trust treatments more when a licensed provider gives them. Nature walks are often prescribed to improve health. But when non-clinical staff lead these walks, patients are less likely to follow through. Even if the service is fully covered, patients see it as less legitimate without a doctor involved. This lack of trust happens even when outcomes are good. It has happened before with community health workers in the UK and US. Preventive services like nature walks face more barriers when no doctor signs off. They also struggle if they are not part of regular care teams. This slowed adoption of expert-recommended preventive services before the ACA. So, unless a licensed provider is involved, patients will not follow nature walk prescriptions as closely as standard treatments. Reimbursement alone is not enough." }, { "source": 99, "target": 161, "relationship": "__anchor__" }, { "source": 161, "target": 162, "relationship": "**Park prescriptions fail to increase patient adherence unless they are integrated into health systems that can track and verify participation.**\n\nIn cities with required green spaces, people follow nature-based health advice more reliably when parks are connected to public health systems. These systems include electronic health records and community health workers. Without formal ways to track and verify prescribed park visits, patients lose motivation to participate. Even if parks are nearby and easy to reach, participation drops when the health system cannot monitor the activity. This occurs because health providers cannot coordinate or reimburse park-based treatments like other medical services. A clear example is the uneven results of park prescription programs under the CDC's REACH initiative. Despite fair access to green spaces, many people did not stick with the program. The reason is simple: health systems fail to track park visits the way they track other care. When parks are not part of official care pathways, engagement remains low." } ], "query": "How would patients react if their doctors started prescribing nature walks instead of pharmaceuticals for mild depression treatment?" }